OMNI
Device
Sight Sciences, Inc.
Total Payments
$1.9M
Transactions
5,440
Doctors
2,399
Companies
2
Payment Trends by Year
| Year | Amount | Transactions | Doctors |
|---|---|---|---|
| 2020 | $1.1M | 2,495 | 1,279 |
| 2019 | $769,970 | 2,938 | 1,526 |
| 2018 | $92.68 | 7 | 7 |
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $844,451 | 103 | 44.4% |
| Consulting Fee | $679,505 | 340 | 35.8% |
| Food and Beverage | $220,674 | 4,830 | 11.6% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $108,500 | 88 | 5.7% |
| Travel and Lodging | $32,079 | 78 | 1.7% |
| Education | $15,000 | 1 | 0.8% |
Payments by Type
General
$1.1M
5,337 transactions
Research
$844,451
103 transactions
Research Studies & Clinical Trials
| Study Name | Sponsor | Amount | Doctors |
|---|---|---|---|
| Prospective Multicenter Post Market Study of Use of the OMNI Surgical System in Combination with Cataract Extraction in Open Angle Glaucoma | Sight Sciences, Inc. | $352,798 | 0 |
| Prospective Multi-Center Post-Market Study of Use of the OMNI Surgical System in Combination With Cataract Extraction in Open Angle Glaucoma | Sight Sciences, Inc. | $181,606 | 0 |
| A Prospective Multicenter Study of the OMNI Surgical System in Pseudophakic Eyes with Open Angle Glaucoma (ORION) | Sight Sciences, Inc. | $146,109 | 0 |
| A Retrospective Observational Multicenter 12 Month Follow Up Study of Patients with Open Angle Glaucoma Treated with the OMNI Surgical System as a Standalone Procedure in Pseudophakic Patients or Combined with Cataract Surgery (ROMEO) | Sight Sciences, Inc. | $54,640 | 2 |
| Multi-Center Prospective Randomized Controlled Clinical Evaluation of the Safety and Effectiveness of the Sight Sciences VISCO360 Viscosurgical System in Canaloplasty Versus Selective Laser Trabeculoplasty in the Reduction of IOP in Primary Open Angle Glaucoma | Sight Sciences, Inc. | $35,748 | 1 |
| A Multicenter Retrospective Study on 3 Month Outcomes of Pseudophakic Viscodilation and Trabeculotomy in Patients with Mild to Moderate Glaucoma | Sight Sciences, Inc. | $26,000 | 0 |
| A Retrospective Observational Multi-Center 12-month Follow-up Study of Patients with Open-Angle Glaucoma Treated with the OMNI Surgical System as a Standalone Procedure in Pseudophakic Patients or Combined with Cataract Surgery (ROMEO) | Sight Sciences, Inc. | $24,900 | 1 |
| A Single Center Retrospective Chart Review of Viscodilation without Trabeculotomy Using the Visco360 and Omni360 Devices | Sight Sciences, Inc. | $14,400 | 1 |
| A Single Center Proof of Concept Study to Assess Intra and Perioperative Safety Profile of OMNI Plus Surgical System | Sight Sciences, Inc. | $8,250 | 1 |
Top Doctors Receiving Payments for OMNI — Page 88
| Doctor | Specialty | Location | Total | Records |
|---|---|---|---|---|
| , D.O | Ophthalmology | Dover, DE | $14.17 | 1 |
| , MD | Ophthalmology | Troy, MI | $14.12 | 1 |
| , MD | Internal Medicine | Chicago, IL | $14.10 | 1 |
| , MD | Ophthalmology | Chicago, IL | $14.10 | 1 |
| , M.D | Student in an Organized Health Care Education/Training Program | Chicago, IL | $14.10 | 1 |
| , M.D | Ophthalmology | Soddy Daisy, TN | $14.10 | 1 |
| Judy Chen | Ophthalmology | Chicago, IL | $14.10 | 1 |
| , O.D | Optometrist | Chicago, IL | $14.10 | 1 |
| , M.D | Ophthalmology | Allentown, PA | $14.10 | 1 |
| , MD | Ophthalmology | Geneva, IL | $14.10 | 1 |
| , M.D | Ophthalmology | Chicago, IL | $14.10 | 1 |
| , MD | Internal Medicine | Chicago, IL | $14.10 | 1 |
| , M.D | Ophthalmology | Chicago, IL | $14.10 | 1 |
| , MD | Ophthalmology | Maywood, IL | $14.10 | 1 |
| , MD | Student in an Organized Health Care Education/Training Program | Maywood, IL | $14.10 | 1 |
| , M.D | Ophthalmology | Chicago, IL | $14.10 | 1 |
| Lincoln Shaw | Ophthalmology | Chicago, IL | $14.10 | 1 |
| , M.D | Ophthalmology | Allentown, PA | $14.09 | 1 |
| , MD | Ophthalmology | New York, NY | $14.09 | 1 |
| , M.D | Ophthalmology | Fall River, MA | $14.09 | 1 |
| , M.D | Ophthalmology | Fort Worth, TX | $14.01 | 3 |
| , MD | Ophthalmology | Salt Lake City, UT | $13.95 | 1 |
| , M.D | Ophthalmology | Bronx, NY | $13.92 | 1 |
| , M.D | Ophthalmology | Faribault, MN | $13.91 | 1 |
| , MD, PHD | Ophthalmology | Los Angeles, CA | $13.89 | 1 |
Ad
Manufacturing Companies
- Sight Sciences, Inc. $1.9M
- Hologic, LLC $92.68
Product Information
- Type Device
- Total Payments $1.9M
- Total Doctors 2,399
- Transactions 5,440
About OMNI
OMNI is a device associated with $1.9M in payments to 2,399 healthcare providers, recorded across 5,440 transactions in the CMS Open Payments database. The primary manufacturer is Sight Sciences, Inc..
Payment data is available from 2018 to 2020. In 2020, $1.1M was paid across 2,495 transactions to 1,279 doctors.
The most common payment nature for OMNI is "Unspecified" ($844,451, 44.4% of total).
OMNI is associated with 9 research studies, including "Prospective Multicenter Post Market Study of Use of the OMNI Surgical System in Combination with Cataract Extraction in Open Angle Glaucoma" ($352,798).